Skip to main content
Clinical Trials/NCT02946229
NCT02946229CompletedNot Applicable

Data Collection for Next Generation Ultrasound Technology Development

GE Healthcare2 sites in 1 country142 target enrollmentStarted: October 26, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
142
Locations
2
Primary Endpoint
Number of Diagnostic Ultrasound Exams

Study Overview

Brief Summary

The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome.

Detailed Description

The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome. All eligible adults (aged 18 or older) will contribute case data from a convenience sample of maintenance hemodialysis population available at the study site and consistent with feasibility assessment of the technology. A relatively large feasibility population is used due to the need to test feasibility of multiple features across variations within this population.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Are adults (aged 18 years of age or older) at the time of consent;
  • Are undergoing maintenance hemodialysis (MHD); AND
  • Are able and willing to provide written informed consent for participation

Exclusion Criteria

  • Have anatomical characteristics or comorbid medical conditions that prevent completion of ultrasound scanning using the study device; OR
  • Are potentially put at additional risk by participating, in the opinion of the investigator.

Arms & Interventions

MHD Population Ultrasound

Other

Eligible subjects in a convenience population at the site (Maintenance Hemodialysis, MHD) incidentally undergoingnon-invasive cardiac, pulmonary, and abdominal ultrasound scanning on the commercially available GE Vivid S70 system for use in testing feasibility of new algorithms for processing this data.

Intervention: Ultrasound scan (Device)

Outcomes

Primary Outcomes

Number of Diagnostic Ultrasound Exams

Time Frame: 1 day

Collection (number) of ultrasound images representative of sonographic findings routinely observed in the general imaging population.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials